Definium Therapeutics (DFTX) Other Non-Current Assets (2022 - 2026)
Definium Therapeutics (DFTX) reported Other Non-Current Assets of $880,000 for Q2 2026, down 25.0% from $1.17 million a year earlier but up 8.4% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Definium Therapeutics posted Other Non-Current Assets of $862,000, up 40.6% from FY2024.
- Other Non-Current Assets has a three-year compound annual growth rate of 37.6% (FY2022 to FY2025).
- By year, Other Non-Current Assets came in at $613,000 in FY2024 (+173.7%), $224,000 in FY2023 (-32.3%) and $331,000 in FY2022.
- Five-year quarterly Other Non-Current Assets spans a low of $144,000 in Q1 2024 and a high of $1.17 million in Q2 2025.
- Year over year, Other Non-Current Assets gained in seven of the last eight quarters, with growth averaging 114.1%.
- The high point for year-over-year Other Non-Current Assets in five years was Q1 2025 (growth of 320.8%); the low point was Q1 2024 (a decline of 52.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $812,000 (Q1 2026), $862,000 (Q4 2025) and $1.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Definium Therapeutics | 3.99 Bn | 1.91 Bn | - | 880,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 880,000.00 |
| Mar 31, 2026 | 812,000.00 |
| Dec 31, 2025 | 862,000.00 |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 606,000.00 |
| Dec 31, 2024 | 613,000.00 |
| Sep 30, 2024 | 493,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 144,000.00 |
| Dec 31, 2023 | 224,000.00 |
| Sep 30, 2023 | 229,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 331,000.00 |
API Access
Definium Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();